Home › NCT06664827

Blood Flow Restriction (BFR) Training on the Ulnar Collateral Ligament (UCL)

Outcomes of Blood Flow Restriction Training on the Ulnar Collateral Ligament

Who can join

Ages 18 to 50 · All sexes · Healthy volunteers welcome

Inclusion Criteria:

* Healthy volunteer
* Agree to complete all exercise sessions and program in its entirety
* Between the ages of 18-50 years old

Exclusion Criteria:

* Current or recent injury of the hand, elbow, or shoulder
* Outside of the ages of 18-50 years old
* Vascular compromise or previous vascular surgery
* History of DVT
* Current participation in other BFR research study
* Currently participating in a structured strength training program
* Any musculoskeletal conditions resulting in inability to exercise
* Participants may not be collegiate/professional baseball/softball players
* Vulnerable populations

About the study

The goal of this clinical trial is to identify any differences in elbow ulnar collateral ligament (UCL) relative thickness and joint space laxity in the dominant arm following an 8-week course of low intensity resistance exercises with blood flow restriction (BFR) exercises in healthy volunteers. The main questions it aims to answer are:

1. Do BFR exercises contribute to a change in the relative ligament thickness of the UCL, and changes in the ulnohumeral joint space? 2. Are there changes in arm strength following the 8-week strengthening protocol with/without BFR?

Participants will:

* Complete two BFR sessions a week for a total of eight weeks. * Complete an exercise session with both arms (dominant arm will receive BFR) at each study visit. * Have sonographs taken of the UCL at the first and last study visit. * Complete strength assessments at the first and last study visit.

What is being tested

• Delfi PTS Blood Flow Restriction Tourniquet System (device)

Sponsor: The Methodist Hospital Research Institute · Participants: 50 · Started: Jan 16, 2025

Contact the study team

• Haley Goble, MHA · Phone: 713-441-3930

Official record on ClinicalTrials.gov — NCT06664827

Locations in the U.S.

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.